Pediatric Heart Disease: The Need for More Rigorous Clinical Evidence

Although congenital heart disease is one of the most common birth defects, its complexity has made the accumulation of an evidence base a challenge. The IMPACT registry, which stands for improving pediatric and adult congenital treatments, has been created to fill this information gap, and it is hoped that these data will provide clinical evidence to help guide treatment for pediatric heart disease. Dr. Gerard Martin, senior vice president for the Center for Heart, Lung and Kidney Disease and co-director of the Children’s National Heart Institute at Children’s National Medical Center, discusses how the IMPACT registry might help improve quality outcomes for our younger patients with congenital heart disease. Dr. Janet Wright hosts.